Drug interactions in hospitalized patients: Critical importance of renal disease and drug monitoring based on data from hospital departments of internal medicine in Serbia.

IF 0.7 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Aneta Drndarević, Ivana Draganov, Milena Kovačević, Miljanka Vuksanović, Aleksandar Janković, Ana Kalaba, Branislava Miljković, Sandra Vezmar Kovačević
{"title":"Drug interactions in hospitalized patients: Critical importance of renal disease and drug monitoring based on data from hospital departments of internal medicine in Serbia.","authors":"Aneta Drndarević, Ivana Draganov, Milena Kovačević, Miljanka Vuksanović, Aleksandar Janković, Ana Kalaba, Branislava Miljković, Sandra Vezmar Kovačević","doi":"10.5414/CP204648","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Drug-drug interactions (DDIs) have been associated with adverse drug reactions (ADRs) which can cause hospitalization. The aim of this study was to associate potential DDIs (pDDIs) with potential ADRs upon admission to hospital among patients on five internal medicine wards.</p><p><strong>Materials and methods: </strong>A cross-sectional study was performed on the cardiology, nephrology, endocrinology, gastroenterology, and geriatrics ward. The patients' sociodemographic characteristics, medical history, clinical and laboratory parameters were recorded.</p><p><strong>Results: </strong>In total, 474 patients participated in the study. The mean age was 69.7 ± 12.8 years. We identified 1,949 pDDIs in 389 patients (82.1%), with an average of 5.0 ± 4.7 (range 1 - 34). angiotensin-converting enzyme inhibitors, loop diuretics, aspirin, and β-blockers were most frequently involved in DDIs, and the most common possible adverse outcomes were renal failure, decreased blood pressure, bleeding, and hypoglycemia. Asthma/chronic obstructive pulmonary disease, heart failure, nephrology ward, number of medications, acute myocardial infarction and diabetes were predictive for clinically relevant pDDIs. Elevated urea and serum creatinine levels were associated with pDDIs resulting in possible renal failure. Anticoagulants were associated with Prothrombin time-international normalized ratio levels >3 (6.23; 3.80 - 10.21; p < 0.001), whereas the presence of pDDIs leading to clopidogrel inefficacy was associated with elevated troponin levels (OR 4.03; 1.96 - 8.27; p < 0.001).</p><p><strong>Conclusion: </strong>We associated comorbidities with different classes of clinically significant pDDIs and possible outcomes such as renal failure, bleeding, and clopidogrel inefficacy with appropriate laboratory parameters outside the reference range. The pDDI-associated inefficacy of clopidogrel may have caused patient hospitalization due to reinfarction.</p>","PeriodicalId":13963,"journal":{"name":"International journal of clinical pharmacology and therapeutics","volume":" ","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical pharmacology and therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CP204648","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Drug-drug interactions (DDIs) have been associated with adverse drug reactions (ADRs) which can cause hospitalization. The aim of this study was to associate potential DDIs (pDDIs) with potential ADRs upon admission to hospital among patients on five internal medicine wards.

Materials and methods: A cross-sectional study was performed on the cardiology, nephrology, endocrinology, gastroenterology, and geriatrics ward. The patients' sociodemographic characteristics, medical history, clinical and laboratory parameters were recorded.

Results: In total, 474 patients participated in the study. The mean age was 69.7 ± 12.8 years. We identified 1,949 pDDIs in 389 patients (82.1%), with an average of 5.0 ± 4.7 (range 1 - 34). angiotensin-converting enzyme inhibitors, loop diuretics, aspirin, and β-blockers were most frequently involved in DDIs, and the most common possible adverse outcomes were renal failure, decreased blood pressure, bleeding, and hypoglycemia. Asthma/chronic obstructive pulmonary disease, heart failure, nephrology ward, number of medications, acute myocardial infarction and diabetes were predictive for clinically relevant pDDIs. Elevated urea and serum creatinine levels were associated with pDDIs resulting in possible renal failure. Anticoagulants were associated with Prothrombin time-international normalized ratio levels >3 (6.23; 3.80 - 10.21; p < 0.001), whereas the presence of pDDIs leading to clopidogrel inefficacy was associated with elevated troponin levels (OR 4.03; 1.96 - 8.27; p < 0.001).

Conclusion: We associated comorbidities with different classes of clinically significant pDDIs and possible outcomes such as renal failure, bleeding, and clopidogrel inefficacy with appropriate laboratory parameters outside the reference range. The pDDI-associated inefficacy of clopidogrel may have caused patient hospitalization due to reinfarction.

住院患者的药物相互作用:基于塞尔维亚医院内科数据的肾脏疾病和药物监测的至关重要性。
药物-药物相互作用(ddi)与可导致住院的药物不良反应(adr)有关。本研究的目的是在5个内科病房的患者中,将潜在的ddi (pddi)与入院时潜在的adr联系起来。材料和方法:对心脏科、肾脏病科、内分泌科、胃肠科和老年科病房进行横断面研究。记录患者的社会人口学特征、病史、临床和实验室参数。结果:共474例患者参与研究。平均年龄69.7±12.8岁。我们在389例(82.1%)患者中发现了1,949个pddi,平均为5.0±4.7(范围1 - 34)。血管紧张素转换酶抑制剂、环状利尿剂、阿司匹林和β受体阻滞剂是ddi中最常见的药物,最常见的不良后果是肾功能衰竭、血压下降、出血和低血糖。哮喘/慢性阻塞性肺疾病、心力衰竭、肾内科病房、用药次数、急性心肌梗死和糖尿病是临床相关pddi的预测指标。尿素和血清肌酐水平升高与pDDIs相关,可能导致肾功能衰竭。抗凝血药物与凝血酶原时间-国际标准化比值水平bbbb3相关(6.23;3.80 - 10.21;p)结论:我们将不同类型的临床显著性pddi的合并症和可能的结局(如肾功能衰竭、出血和氯吡格雷无效)与参考范围外的适当实验室参数相关联。氯吡格雷与pdi相关的无效可能导致患者因再梗死而住院。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.70
自引率
12.50%
发文量
116
审稿时长
4-8 weeks
期刊介绍: The International Journal of Clinical Pharmacology and Therapeutics appears monthly and publishes manuscripts containing original material with emphasis on the following topics: Clinical trials, Pharmacoepidemiology - Pharmacovigilance, Pharmacodynamics, Drug disposition and Pharmacokinetics, Quality assurance, Pharmacogenetics, Biotechnological drugs such as cytokines and recombinant antibiotics. Case reports on adverse reactions are also of interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信